Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma. [electronic resource]
Producer: 20170512Description: 413-24 p. digitalISSN:- 1476-5586
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Bone Marrow Cells -- cytology
- Carcinoma, Hepatocellular -- drug therapy
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Endothelial Progenitor Cells -- cytology
- Human Umbilical Vein Endothelial Cells -- cytology
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Nude
- Mice, Transgenic
- Neovascularization, Pathologic -- drug therapy
- Receptors, Vascular Endothelial Growth Factor
- Recombinant Fusion Proteins -- pharmacology
- Vascular Endothelial Growth Factor Receptor-1 -- metabolism
- Vascular Endothelial Growth Factor Receptor-2 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.